StreetInsider.com News Articles

Form 4 FATE THERAPEUTICS INC For: Jun 12 Filed by: Lee Michael Stewart

Mon, 15 Jun 2026 17:16:00 -0400

si-local-file:///var/storage/secattach/20260615/26648592.html

Form 4 FATE THERAPEUTICS INC For: Jun 12 Filed by: Lee Michael Stewart

Mon, 15 Jun 2026 17:16:00 -0400

si-local-file:///var/storage/secattach/20260615/26648592.html

Form 4 FATE THERAPEUTICS INC For: Jun 12 Filed by: Redmile Group, LLC

Mon, 15 Jun 2026 17:16:00 -0400

si-local-file:///var/storage/secattach/20260615/26648602.html

Form 4 FATE THERAPEUTICS INC For: Jun 12 Filed by: Redmile Group, LLC

Mon, 15 Jun 2026 17:16:00 -0400

si-local-file:///var/storage/secattach/20260615/26648602.html

Form 4 FATE THERAPEUTICS INC For: Jun 12 Filed by: Jooss Karin

Mon, 15 Jun 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260615/26647403.html

Form 4 FATE THERAPEUTICS INC For: Jun 12 Filed by: Jooss Karin

Mon, 15 Jun 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260615/26647403.html

Form 4 FATE THERAPEUTICS INC For: Jun 12 Filed by: Xu Yuan

Mon, 15 Jun 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260615/26647425.html

Form 4 FATE THERAPEUTICS INC For: Jun 12 Filed by: Xu Yuan

Mon, 15 Jun 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260615/26647425.html

Form 4 FATE THERAPEUTICS INC For: Jun 12 Filed by: EPSTEIN ROBERT S

Mon, 15 Jun 2026 16:09:00 -0400

si-local-file:///var/storage/secattach/20260615/26647386.html

Form 4 FATE THERAPEUTICS INC For: Jun 12 Filed by: EPSTEIN ROBERT S

Mon, 15 Jun 2026 16:09:00 -0400

si-local-file:///var/storage/secattach/20260615/26647386.html

Form 4 FATE THERAPEUTICS INC For: Jun 12 Filed by: Agarwal Shefali

Mon, 15 Jun 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260615/26647372.html

Form 4 FATE THERAPEUTICS INC For: Jun 12 Filed by: Agarwal Shefali

Mon, 15 Jun 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260615/26647372.html

Form 4 FATE THERAPEUTICS INC For: Jun 12 Filed by: ABERNETHY MATT

Mon, 15 Jun 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260615/26647354.html

Form 4 FATE THERAPEUTICS INC For: Jun 12 Filed by: ABERNETHY MATT

Mon, 15 Jun 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260615/26647354.html

Form 4 FATE THERAPEUTICS INC For: Jun 12 Filed by: RASTETTER WILLIAM H

Mon, 15 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260615/26647335.html

Form 4 FATE THERAPEUTICS INC For: Jun 12 Filed by: RASTETTER WILLIAM H

Mon, 15 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260615/26647335.html

Form 4 FATE THERAPEUTICS INC For: Jun 12 Filed by: Hamill Laura

Mon, 15 Jun 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260615/26647290.html

Form 4 FATE THERAPEUTICS INC For: Jun 12 Filed by: Hamill Laura

Mon, 15 Jun 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260615/26647290.html

Form 3 FATE THERAPEUTICS INC For: Jun 12 Filed by: Hamill Laura

Mon, 15 Jun 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260615/26647229.html

Form 3 FATE THERAPEUTICS INC For: Jun 12 Filed by: Hamill Laura

Mon, 15 Jun 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260615/26647229.html

Form 8-K FATE THERAPEUTICS INC For: Jun 12

Mon, 15 Jun 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260615/26647204.html

Form 8-K FATE THERAPEUTICS INC For: Jun 12

Mon, 15 Jun 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260615/26647204.html

Fate Therapeutics appoints Laura Hamill to board of directors

Mon, 15 Jun 2026 08:30:12 -0400

Fate Therapeutics, Inc. (NASDAQ: FATE) announced the appointment of Laura Hamill to its board of directors. Hamill brings more than three decades of commercial and strategic management experience in the biopharmaceutical industry.

Hamill most recently served as Executive Vice President, Worldwide Commercial Operations at Gilead Sciences, Inc., where she oversaw approximately $22 billion in annual revenue and managed an organization of 2,500 employees. Prior to Gilead, she spent nearly two decades at Amgen, where she held roles of increasing responsibility in the United States and internationally.

At Amgen, Hamill served as Senior Vice President, U.S. Commercial Operations, overseeing the business unit representing

Fate Therapeutics Appoints Laura Hamill to Board of Directors

Mon, 15 Jun 2026 08:30:00 -0400

Accomplished global commercial operations leader brings deep experience launching and scaling biopharmaceutical products as Fate advances its pipeline toward commercialization

SAN DIEGO, June 15, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies broadly to patients with cancer and autoimmune diseases, today announced the appointment of Laura Hamill to its Board of Directors. Ms. Hamill is a global senior executive with more than three decades of commercial and strategic management experience across the biopharmaceutical industry.

“We are delighted

Fate Therapeutics Appoints Laura Hamill to Board of Directors

Mon, 15 Jun 2026 08:30:00 -0400

Accomplished global commercial operations leader brings deep experience launching and scaling biopharmaceutical products as Fate advances its pipeline toward commercialization

“We are delighted